2024 Annual Meeting | C162 - Health Equity for Neurologists

��ɫ��

2024 Annual Meeting | C162 - Health Equity for Neurologists

Date Wednesday 04/17/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Farrah J. Mateen, MD, PhD, FAAN

Topic(s) Health Care Disparities

Learning Objectives 1) To appreciate the terminology of health equity and health disparities and apply it meaningfully to neurological research and practice
2) To appreciate global issues in health equity in neurology, focusing on special populations and the distribution of neurological care from a worldwide perspective
3) To emphasize practical issues in neurological care that relate to health equity
4) To illustrate ways in which neurologists can have a teaching role in health equity and curricular design

CME Available 2.00 CME credits

Core Competencies Interpersonal and Communication Skills, Professionalism, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Brain Health, Diversity, Equity, and Inclusion

Teaching Styles Didactic, Audience Participation

Event Timeline
01:10 PM - 01:40 PM MDT	Speaker	Global Health Equity in Neurology Farrah J. Mateen, MD, PhD, FAAN
01:40 PM - 02:10 PM MDT	Speaker	Overlooked Disparities: A Report from the Trenches Karen L. Skjei, MD
02:10 PM - 02:40 PM MDT	Speaker	Health Equity ��ɫ�� for Neurologists Jillian M. Berkman, MD

Faculty Disclosures
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Jillian M. Berkman, MD	Dr. Berkman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medzown. Dr. Berkman has stock in Medzown.
Karen L. Skjei, MD	Dr. Skjei has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��